- Home
- RVPHW vs TCBIO Comparison
RVPHW vs TCBIO Comparison
Compare RVPHW & TCBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- TCBIO
- Stock Information
- Founded
- RVPHW 2018
- TCBIO N/A
- Country
- RVPHW United States
- TCBIO United States
- Employees
- RVPHW 14
- TCBIO 1818
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- TCBIO Major Banks
- Sector
- RVPHW Health Care
- TCBIO Finance
- Exchange
- RVPHW Nasdaq
- TCBIO Nasdaq
- Market Cap
- RVPHW N/A
- TCBIO N/A
- IPO Year
- RVPHW N/A
- TCBIO N/A
- Fundamental
- Price
- RVPHW $0.06
- TCBIO $20.39
- Analyst Decision
- RVPHW
- TCBIO
- Analyst Count
- RVPHW 0
- TCBIO 0
- Target Price
- RVPHW N/A
- TCBIO N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- TCBIO N/A
- Earning Date
- RVPHW 03-14-2025
- TCBIO N/A
- Dividend Yield
- RVPHW N/A
- TCBIO N/A
- EPS Growth
- RVPHW N/A
- TCBIO N/A
- EPS
- RVPHW N/A
- TCBIO N/A
- Revenue
- RVPHW N/A
- TCBIO N/A
- Revenue This Year
- RVPHW N/A
- TCBIO N/A
- Revenue Next Year
- RVPHW N/A
- TCBIO N/A
- P/E Ratio
- RVPHW N/A
- TCBIO N/A
- Revenue Growth
- RVPHW N/A
- TCBIO N/A
- 52 Week Low
- RVPHW $0.13
- TCBIO N/A
- 52 Week High
- RVPHW $0.15
- TCBIO N/A
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- TCBIO 46.35
- Support Level
- RVPHW N/A
- TCBIO $20.25
- Resistance Level
- RVPHW N/A
- TCBIO $20.97
- Average True Range (ATR)
- RVPHW 0.00
- TCBIO 0.24
- MACD
- RVPHW 0.00
- TCBIO -0.03
- Stochastic Oscillator
- RVPHW 0.00
- TCBIO 20.06
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About TCBIO Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.